Expanded lung cancer screening and smoking cessation programs could prevent tens of thousands of deaths, but systemic barriers and outdated criteria leave high-risk communities behind.

Two modeling studies suggest that making more people eligible for lung cancer screening would prevent tens of thousands of ...

The lung cancer screening system “is not a risk assessment. It is a judgment system designed as one,” writes the director of ...

Nov 1 (Reuters) - New lung cancer screening guidelines issued by the American Cancer Society (ACS) on Wednesday call for annual testing with low‐dose computed tomography (CT) for anyone aged 50 to 80 ...

Smokers and former smokers who are 50 to 80 years old should get lung cancer screenings, according to the American Cancer Society (ACS). The new ACS guideline recommends yearly screening for lung ...

Low-dose computed tomography (LDCT), a procedure that uses X-rays to produce a series of images at different angles, ...

INDIANAPOLIS — Lung cancer is the deadliest cancer in the United States. Every year, lung cancer claims more lives than breast, prostate and colon cancer combined. The reason is it so deadly? It often ...

Lung cancer is the second most common cancer in the United States and is the leading cause of death from cancer. If lung cancer is found early, when it is small and before it has spread, it is more ...

Lung cancer screening can save lives, but it isn't accessible to everyone at risk of developing the disease. sudok1/iStock via Getty Images Plus Many medical organizations have been recommending lung ...

A new program launched by UR Medicine primary care in 2022 has helped more than double lung screening rates. A recent study ...

Low-dose computed tomography (LDCT), a technique that uses X-rays to create detailed images of the lungs, has shown efficacy in diagnosing high-risk individuals, including older adults and smokers.

FANSS study data presented at ESMO Asia 2025 demonstrate the feasibility of screening Asian women who do not smokePALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of ...